Home › Trial NCT00946920
A Trial of Degarelix in Patients With Prostate Cancer
- Trial IDNCT00946920
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorFerring Pharmaceuticals
- Enrollment859
- Start date2009-06
- ConditionsProstate Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.